Next Generation Pharmaceutical Summit 2008.

The NGP Summit has grown to become the standard for senior level pharmaceutical executives looking to share ideas with peers, build partnerships with industry thought leaders, and hear from key experts on how to address some of their most pressing challenges in clinical and drug development. Going forward in 2008, we are dedicated to really listening to the needs of our delegates and providing the best solutions for them to drive their research and development processes in the right direction more efficiently and more effectively. We hope that you will join us in Scottsdale, Arizona on September 2nd to 4th September 2008 for our best event yet, with more delegates, better workshops, more networking opportunities, and the best solution providers in the industry.

Today, the drug industry faces relentless pressure to become faster and more efficient. Exploring new opportunities for fundamental changes in clinical development and leveraging the key benefits of new technologies and systems while efficiently integrating and managing data processes is more important than ever for streamlining operations and making drug development more effective. Adoption of new technologies has the potential to change everything about how clinical data management in accomplished in clinical research. Progress in medicine simply does not happen without clinical trials. This summit’s special focus explores all facets of clinical trials and makes sense of the impacts of broad technology adoption on the clinical environment. Industry leading executives responsible for the world’s most successful pharmaceutical companies in the world will come together to lend their insight and strategies for best practice solutions in integrating and managing data processes in the clinical arena.

more >>

“The event was truly engaging and the format was terrific, informative and provocative.  While I have worked with both Michael Shi (Novartis) and Robert Pietrusko (Viropharma) who have attended the NGP Sumit before, I had not contacted them to discuss their experience.  They both were as enthusiastic the second time around.  As I said to a few, I recently attended DIA, but got more leads out of the 2 days at the NGP Summit than the 4 days at DIA.”
Angus Grant VP, Regulatory Affairs, Celgene

“It’s been a good summit and I’ve had opportunity to interact with lots of vendors and see new technologies that I think will be applicable to our business.”
Alejandro Arruffo VP, Global Pharmaceutical Development, Abbott

“The conference was a great opportunity to meet a lot of people in a very short time rather than having to set up two hour meetings in a busy schedule. It’s a great opportunity to get contact with those people you wouldn’t necessarily let them in the door because I don’t know enough about them. It’s great for those small companies to get the chance to talk to those in bigger companies   This is the first time I’ve been to this conference and its format is very different to any pharmaceutical development conference I’ve ever been to and is really outstanding in terms of having much more time to interact with the other participants and to ask in depth questions and have a dialogue. I have found it very, very productive with the people I’ve met and the information I have been exposed to.”
Doug Sporn, (Formerly) Divisional VP, Regulatory Intelligence & FDA Liason Office, Abbott